Neuro-NOS Israel ltd.

NeuroNOS is a biopharmaceutical company developing novel therapies for neurological and neurodevelopmental disorders, focusing on modulating nitric oxide signaling to restore brain function and address the underlying biology of conditions such as autism.

Selective modulation of neuronal nitric oxide synthase (nNOS) to balance nitric oxide levels and reduce nitrosative stress in neural tissue.

Autism spectrum disorder, rare neurodevelopmental & neurological conditions (e.g., Alzheimer’s, brain cancer).

Amir Avniel - CEO